| Advantages | Compared to iPSC-derived organoids, rectum and colon organoids more closely mimic the in vivo intestinal environment during long-term culture, making them a powerful platform for disease modeling, drug screening, precision medicine, and regenerative research. |
| Species | Human |
| Product Type | Tissue-derived Organoid |
| Growth Properties | Embedded 3D Culture |
| Growth Conditions | Cultured at 37°C under 95% air and 5% CO2. |
| Quality Control | Negative for mycoplasma, bacteria, yeast, and fungi. |
| Tissue | Colon |
| Disease | Normal |
| Format | Frozen |
| Organoid Characterization | They faithfully preserve the physiological architecture and molecular pathology of the original tissue, exhibiting high genetic stability and mature epithelial phenotypes. |
| Applications | Tissue-derived organoids are extensively used in drug screening, disease modeling, mechanistic studies, personalized medicine, and regenerative medicine. By faithfully modeling disease states, they provide an ideal platform for evaluating patient-specific drug responses and supporting personalized treatment design. Furthermore, these organoids drive the development of novel therapeutic approaches, particularly in cancer research and organ regeneration, offering precise experimental tools that accelerate progress in precision medicine. |
| Storage | Liquid Nitrogen |
| Shipping Information | Dry Ice |
For preclinical research and development use only; not intended for therapeutic or other applications.
Alfa Cytology is a preclinical research service provider specializing in tumor organoid development. We provide one-stop services that include tailored 3D cancer models, organoid-based research services, and related products to accelerate the discovery and development of cancer therapeutics.
Copyright © 2026 Alfa Cytology. All rights reserved.